Search

Search Constraints

You searched for: Author/Creator Hié, Miguel

Search Results

1. Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter. Issue 11 (8th July 2019)

2. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Issue 7 (13th June 2012)

4. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort. (28th September 2021)

5. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Issue 6 (24th April 2020)

6. Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'. Issue 12 (1st October 2020)

7. Efficacy and safety of rituximab for systemic lupus erythematosus‐associated immune cytopenias: A multicenter retrospective cohort study of 71 adults. Issue 3 (25th January 2018)

8. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α. Issue 12 (16th August 2022)

9. OP0043 WITHDRAWAL OF A LOW DOSE (5 MG) OF CORTICOSTEROIDS IN SYSTEMIC LUPUS IN REMISSION FOR MORE THAN A YEAR IS AT RISK OF RELAPSE – THE CORTICOLUP TRIAL. (June 2019)

10. Sjögren Sensory Neuronopathy (Sjögren Ganglionopathy): Long-Term Outcome and Treatment Response in a Series of 13 Cases. Issue 19 (May 2016)